In line with our previous data, we demonstrated that tianeptine has the ability to diminish depression-like behavior (in an animal model of depression) via normalization of the IGF-1 family network, as well as through cytokines and the chemokine/chemokine receptor axis [30,31]. This evidence concerns the gene IGF1 and depressive disorder.